[SLN] QoQ Quarter Result on 30-Jun-2024 [#Q2]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
15-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -729.53%
YoY- -49.62%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 598 12,406 2,099 2,798 9,104 11,374 4,765 -74.96%
PBT -17,441 -3,365 -14,966 -10,661 -12,010 -12,673 -15,050 10.33%
Tax -1,879 -1,489 -554 -2,411 -1,609 -2,469 -1,287 28.72%
NP -15,562 -1,876 -14,412 -8,250 -10,401 -10,204 -13,763 8.54%
Tax Rate - - - - - - - -
Total Cost 16,160 14,282 16,511 11,048 19,505 21,578 18,528 -8.72%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -2,602.34 -15.12 -686.61 -294.85 -114.25 -89.71 -288.84 333.56%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.33 -0.04 -0.37 -0.22 -0.29 -0.28 -0.43 -16.19%
EPS Diluted -0.33 -0.04 -0.37 -0.22 -0.29 -0.28 -0.43 -16.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.